Hepatic uptake of technetium-99m HM-PAO in a fetus.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2313364.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The normal biodistribution of technetium-99m HM-PAO ([99mTc]HM-PAO) includes significant uptake in the brain, liver, and kidneys. A pregnant patient studied with [99mTc] HM-PAO to confirm brain death provided an opportunity to examine the transplacental distribution of this radio-pharmaceutical in the unborn fetus. Uptake in the fetus after transplacental delivery is almost exclusively hepatic with a small amount of biliary excretion.
Medical subject headings
- Brain Death
- Fetus
- Liver
- Organotechnetium Compounds
- Oximes
- Pregnancy Complications